These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 17002261)
1. Prospects for the development of novel anti-hyperlipidemic drugs. Derosa G; Salvadeo S; Cicero AF Curr Opin Investig Drugs; 2006 Sep; 7(9):826-33. PubMed ID: 17002261 [TBL] [Abstract][Full Text] [Related]
2. [New results in the management of hypercholesterolemia]. Sármán B Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867 [TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia and atherosclerosis. A forecast of pharmaceutical approaches. Gotto AM Circulation; 1993 Apr; 87(4 Suppl):III54-9. PubMed ID: 8462181 [TBL] [Abstract][Full Text] [Related]
4. The treatment of dyslipidemia--what's left in the pipeline? Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209 [TBL] [Abstract][Full Text] [Related]
6. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]
7. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Linsel-Nitschke P; Tall AR Nat Rev Drug Discov; 2005 Mar; 4(3):193-205. PubMed ID: 15738977 [TBL] [Abstract][Full Text] [Related]
8. [Therapy of dyslipidemia in post-infarction: state of the art]. Borgia MC; Nardi M; Da Ros S; Castellano V Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719 [TBL] [Abstract][Full Text] [Related]
9. The use of lipid-lowering drug therapy in children and adolescents. Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879 [TBL] [Abstract][Full Text] [Related]
10. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582 [TBL] [Abstract][Full Text] [Related]
11. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099 [TBL] [Abstract][Full Text] [Related]
12. Who needs to care about small, dense low-density lipoproteins? Rizzo M; Berneis K Int J Clin Pract; 2007 Nov; 61(11):1949-56. PubMed ID: 17935554 [TBL] [Abstract][Full Text] [Related]